1. Home
  2. Labeler Index
  3. Novartis Pharmaceuticals Corporation
  4. 0078-0671
  5. Product Images: Tykerb

Product Images Tykerb

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Tykerb NDC 0078-0671 by Novartis Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

lapatinib ditosylate monohydrate chemical structure - tykerb spl graphic 01

lapatinib ditosylate monohydrate chemical structure - tykerb spl graphic 01

Figure 1 - tykerb spl graphic 02

Figure 1 - tykerb spl graphic 02

Figure 2 - tykerb spl graphic 03

Figure 2 - tykerb spl graphic 03

Figure 3 - tykerb spl graphic 04

Figure 3 - tykerb spl graphic 04

bottle label - tykerb spl graphic 05

bottle label - tykerb spl graphic 05

This is a description of a medication package. The medication is lapatinib, which comes in tablet form with each tablet containing 358 mg of lapatinib ditoylte, equivalent to 250 mlapati. The recommended dosage is not provided, and users should refer to the prescribing information. The medication should be stored at temperatures between 20°C and 25°C, with excursions permitted between 15°C and 30°C. The package includes 150 tablets distributed by Novartis Pharmaceuticals Corp, located in New Jersey, USA. The product has a unique identifier code, NDC 0078-0671-19. It also includes instructions for healthcare professionals to use safety closures.*

tykerb spl graphic 06

tykerb spl graphic 06

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.